George Sellers
Stock Analyst at Stephens & Co.
(1.28)
# 3,290
Out of 4,828 analysts
43
Total ratings
25%
Success rate
-9.53%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $33.92 | +100.47% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $125.11 | +131.80% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $41.72 | +39.02% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $111.50 | +59.64% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $11.64 | +106.19% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $33.01 | +118.12% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.16 | +331.03% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.82 | +266.57% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $19.42 | +193.51% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $89.96 | -21.08% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $33.92
Upside: +100.47%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $125.11
Upside: +131.80%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $41.72
Upside: +39.02%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $111.50
Upside: +59.64%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $11.64
Upside: +106.19%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $33.01
Upside: +118.12%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.16
Upside: +331.03%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.82
Upside: +266.57%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $19.42
Upside: +193.51%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $89.96
Upside: -21.08%